Novavax Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -228.8% | – | – | – | |
| – | +35.2% | +42.2% | +15.4% | -16.9% | -30.4% | -13.9% | +159.2% | +129.5% | +41.9% | +17.6% | -43.1% | |
| – | +120.5% | +42.7% | +3.4% | -7.5% | -6.9% | +651.0% | +43.4% | -29.0% | -34.5% | -43.6% | -25.2% | |
| – | +147.1% | +46.3% | +14.3% | -49.6% | +13.1% | +758.7% | +57.8% | +226.2% | – | – | – | |
| – | +40.9% | -203.5% | – | -332.2% | – | – | +14,326.4% | -120.8% | – | – | -1,931.0% | |
| – | +151.6% | -0.4% | -77.0% | -67.2% | +35.3% | +2,841.4% | +5.2% | +61.8% | -36.8% | -77.8% | -57.4% | |
| – | -83.6% | – | +28.4% | -20.5% | +34.6% | -1,081.4% | – | -192.8% | -36.8% | +247.0% | -61.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +88.9% | -98.2% | +1,598.5% | +59.2% | -4.3% | -139.7% | – | – | – | – | – | |
| – | -0.5% | – | -100.0% | +259,535.1% | +0.0% | +0.0% | +33.1% | – | -531.5% | -98.9% | – | |
| – | +89.8% | +34.0% | -76.9% | +59.3% | -4.3% | +900.9% | -53.1% | -29.6% | -98.6% | +5,734.8% | -89.4% | |
| – | – | -15.7% | -174.2% | – | – | +256,261.1% | +55.2% | -120.4% | – | – | – | |
| – | – | – | – | – | – | – | – | -291.7% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.